In this report, we investigated the function of Fbxw7 in HCC, then treated HCC cells with rAd-p53 and evaluated p53, Fbxw7, c-Myc and Cyclin E expression and anti-tumor activities in vitro and in vivo. The gene discussed is FBXW7; the disease is hepatocellular carcinoma.